SUPREME COURT MEDTRONIC V. LOHR RULING LEAVES POSSIBILITY OF TORT CLAIM PREEMPTION BY PMA REQUIREMENTS; PREEMPTION FOR 510(K) DEVICES ELIMINATED
This article was originally published in The Gray Sheet
Executive Summary
The Supreme Court's ruling June 26 in the case of Medtronic v. Lohr includes opinions from five justices that leave open the possibility that premarket approval application requirements could preempt liability claims.
You may also be interested in...
With Scalia’s Passing, Device Industry Loses Preemption Supporter On Supreme Court
Justice Antonin Scalia’s death is not likely to have any immediate impact on the device industry – but at least one observer speculates that, down the road, more cases against manufacturers might be allowed to move forward in the lower courts despite preemption defense.
Wyeth Supreme Court Case Could Have Impact On Device Suits, Lawyers Say
If the Supreme Court favors "implied" federal pre-emption for FDA-approved pharmaceutical labeling in a case that will be heard by the court next month, some devices may receive additional protections too, lawyers suggest
Wyeth Supreme Court Case Could Have Impact On Device Suits, Lawyers Say
If the Supreme Court favors "implied" federal pre-emption for FDA-approved pharmaceutical labeling in a case that will be heard by the court next month, some devices may receive additional protections too, lawyers suggest